General Information of the Compound
Compound ID
CP0740125
Compound Name
(3-Bromo-phenyl)-(5H-pyrimido[5,4-b]indol-4-yl)-amine hydrochloride
    Show/Hide
Formula
C16H12BrClN4
Molecular Weight
375.657
Canonical SMILES
Brc1cccc(Nc2[nH]cnc3c4ccccc4nc2-3)c1.Cl
    Show/Hide
InChI
InChI=1S/C16H11BrN4.ClH/c17-10-4-3-5-11(8-10)20-16-15-14(18-9-19-16)12-6-1-2-7-13(12)21-15;/h1-9,20H,(H,18,19);1H
    Show/Hide
InChIKey
OBFMRMXLCQBKKM-UHFFFAOYSA-N
Physicochemical Property
logP
4.9906
Rotatable Bonds
2
Heavy Atom Count
22
Polar Areas
53.6
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL554983
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 = 93 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 72 nM